X4 Pharmaceuticals Inc (XFOR)
1.015
+0.04
(+4.01%)
USD |
NASDAQ |
May 31, 16:00
1.02
0.00 (0.00%)
Pre-Market: 20:00
X4 Pharmaceuticals Total Liabilities (Quarterly): 111.15M for March 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 111.15M |
| December 31, 2023 | 96.16M |
| September 30, 2023 | 105.70M |
| June 30, 2023 | 105.86M |
| March 31, 2023 | 72.73M |
| December 31, 2022 | 81.54M |
| September 30, 2022 | 51.56M |
| June 30, 2022 | 50.95M |
| March 31, 2022 | 49.91M |
| December 31, 2021 | 52.76M |
| September 30, 2021 | 51.84M |
| June 30, 2021 | 52.45M |
| March 31, 2021 | 54.10M |
| December 31, 2020 | 50.07M |
| Date | Value |
|---|---|
| September 30, 2020 | 43.42M |
| June 30, 2020 | 37.65M |
| March 31, 2020 | 34.93M |
| December 31, 2019 | 31.48M |
| September 30, 2019 | 30.43M |
| June 30, 2019 | 37.34M |
| March 31, 2019 | 33.11M |
| December 31, 2018 | 14.40M |
| September 30, 2018 | 18.00M |
| June 30, 2018 | 19.45M |
| March 31, 2018 | 20.80M |
| December 31, 2017 | 22.55M |
| September 30, 2017 | 25.56M |
| December 31, 2016 | 64.17M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
30.43M
Minimum
Sep 2019
111.15M
Maximum
Mar 2024
60.10M
Average
51.70M
Median
Total Liabilities (Quarterly) Benchmarks
| Phio Pharmaceuticals Corp | 1.249M |
| Ocular Therapeutix Inc | 130.96M |
| Alpine Immune Sciences Inc (DELISTED) | 40.94M |
| Scholar Rock Holding Corp | 84.51M |
| RAPT Therapeutics Inc | 24.98M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 112.18M |
| Shareholders Equity (Quarterly) | 1.036M |